Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids
- PMID: 27832795
- PMCID: PMC5103510
- DOI: 10.1186/s12969-016-0119-z
Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids
Abstract
Background: Rheumatic diseases are associated with an increased fracture risk. The tissue level characteristics of the bone involvement in children have not been well elucidated. Our objectives were to describe the bone micro-architectural characteristics in children with rheumatic diseases on chronic glucocorticoids, and to determine associations between micro-architectural findings with clinical and radiological variables.
Methods: Children on chronic glucocorticoids for an underlying rheumatic disease were referred for evaluation of bone fragility given the presence of vertebral compression fractures. A trans-iliac bone biopsy was performed as part of the clinical assessment. Histomorphometric analysis and quantitative backscattered electron imaging (qBSE) of the biopsy samples were undertaken.
Results: Data of 15 children (14.0 ± 3.2 years) with a duration of glucocorticoid exposure of 6.2 ± 4.1 years and average prednisone dose of 14.1 ± 6.2 mg/m2/day were assessed. Histomorphometric analyses demonstrated significant decrease in trabecular thickness (p = 0.01), osteoid thickness (p < 0.01), osteoblast surface (p = 0.02) and increase in trabecular separation (p = 0.04) compared to published age-matched normative data. Severity of the trabecular deficit was correlated to glucocorticoid dose, height and body mass index Z score, but not bone mineral density or measures of disease activity. Using qBSE to measure bone mineralization, the subjects were shown to have a heterogeneous and hypermineralized profile, with higher cumulative glucocorticoid dose being associated with greater mineralization (p < 0.01).
Conclusions: In children with rheumatic diseases presenting with vertebral fractures, there is evidence of abnormal bone matrix mineralization and impairments of bone micro-architecture that correlate to glucocorticoid dose.
Keywords: Bone histomorphometry; Bone mineralization; Glucocorticoids; Juvenile idiopathic arthritis; Osteoporosis; Systemic lupus erythematosis.
Similar articles
-
Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders.J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5195-e5207. doi: 10.1210/clinem/dgab494. J Clin Endocrinol Metab. 2021. PMID: 34232311
-
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.J Bone Miner Res. 2015 Sep;30(9):1667-75. doi: 10.1002/jbmr.2511. Epub 2015 May 26. J Bone Miner Res. 2015. PMID: 25801315 Free PMC article.
-
Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis.J Bone Miner Res. 2000 Jan;15(1):13-9. doi: 10.1359/jbmr.2000.15.1.13. J Bone Miner Res. 2000. PMID: 10646109
-
The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature.Semin Arthritis Rheum. 2016 Aug;46(1):49-63. doi: 10.1016/j.semarthrit.2016.02.003. Epub 2016 Feb 26. Semin Arthritis Rheum. 2016. PMID: 27020068 Review.
-
Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.Paediatr Drugs. 2017 Jun;19(3):193-211. doi: 10.1007/s40272-017-0219-3. Paediatr Drugs. 2017. PMID: 28290112 Review.
Cited by
-
Risk factors for nonunion of bone fracture in pediatric patients: An inception cohort study of 237,033 fractures.Medicine (Baltimore). 2018 Aug;97(31):e11691. doi: 10.1097/MD.0000000000011691. Medicine (Baltimore). 2018. PMID: 30075567 Free PMC article.
-
Evaluation of Bone Mineral Density in Juvenile Systemic Lupus Erythematosus.Arch Bone Jt Surg. 2023;11(12):777-782. doi: 10.22038/ABJS.2023.70697.3311. Arch Bone Jt Surg. 2023. PMID: 38146515 Free PMC article.
-
[Fractures and bone mineral density in childhood].Z Rheumatol. 2019 Sep;78(7):636-644. doi: 10.1007/s00393-019-0671-2. Z Rheumatol. 2019. PMID: 31338681 Review. German.
-
Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study.Front Endocrinol (Lausanne). 2025 May 23;16:1587985. doi: 10.3389/fendo.2025.1587985. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40487764 Free PMC article.
-
Fracture nonunion and delayed union.J Pediatr Soc North Am. 2024 Apr 9;7:100058. doi: 10.1016/j.jposna.2024.100058. eCollection 2024 May. J Pediatr Soc North Am. 2024. PMID: 40433283 Free PMC article.
References
-
- Alsufyani KA, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Nadel H, Malleson PN. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol. 2005;32:729–33. - PubMed
-
- Reyes ML, Hernandez MI, King A, Vinet AM, Vogel A, Lagomarsino E, Mericq MV, Mendez C, Gederlini A, Talesnik E. Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures. Clin Exp Rheumatol. 2007;25:329–35. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical